EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis

Hemiao Cui, Haixia Ji iD, Lu Zhang, Wenwen Zhang, Ruixia Kang, Yan Ni, Xuliang Hao iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Hemiao Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Provincial Institute of Traditional Chinese Medicine, Taiyuan, People's Republic of China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Polysaccharides, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Young Qihuang Scholars Support Program, Shanxi Provincial Administration of Traditional Chinese Medicine Chinese Medicine Innovation Team Building Program, State Administration of Traditional Chinese Medicine High-level Chinese Medicine Key Discipline Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cirrhosis is a severe chronic liver disease that typically develops as a result of prolonged hepatic injury and subsequent fibrosis, often driven by immune‐mediated mechanisms, inflammatory responses, and oxidative stress. Polysaccharides derived from traditional Chinese medicine (TCM) are prominent constituents of herbal formulations widely employed in the management of cirrhosis and have demonstrated significant efficacy in alleviating clinical symptoms. This review aims to elucidate the potential roles and immunomodulatory mechanisms of TCM polysaccharides in the intervention of cirrhosis. A systematic search was conducted using PubMed and China National Knowledge Infrastructure (CNKI), with keywords including “Traditional Chinese medicine polysaccharides,” “liver cirrhosis,” and “liver fibrosis,” focusing primarily on studies published within the last 5 years. A limited number of foundational older references were also included. After screening for relevance, language (English/Chinese), and full‐text availability, 104 articles were analyzed. Signaling pathways such as transforming growth factor‐beta1 (TGF‐β1)/Smads, mitogen‐activated protein kinase (MAPK), nuclear transcription factor‐kappaB (NF‐κB), interleukin‐22 (IL‐22)/signal transducer and activator of transcription 3 (STAT3), and wingless‐related integration site (Wnt)/β‐catenin, as well as various cytokines, have been identified as critical in the progression of cirrhosis. TCM polysaccharides exert their therapeutic effects on cirrhosis through the modulation of immune mechanisms within hepatocytes, thereby inhibiting liver fibrosis, alleviating oxidative stress, and suppressing inflammatory responses. TCM polysaccharides exhibit substantial therapeutic potential for treating cirrhosis through their immunomodulatory effects. These findings indicate that TCM polysaccharides warrant further investigation and clinical translation to fully realize their potential in managing cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisPolysaccharidesDrugs, Chinese HerbalHumansMedicine, Chinese TraditionalAnimalsSignal TransductionTransforming Growth Factor beta1NF-kappa B

Stichwörter der Autor:innen

Chinese traditionalfibrosisimmunityliver cirrhosismedicinepolysaccharides

Substanzen

PolysaccharidesDrugs, Chinese HerbalTransforming Growth Factor beta1NF-kappa B

Autor:innen und Institutionen

  • Shanxi Provincial Institute of Traditional Chinese Medicine, Taiyuan, People's Republic of China.
  • School of Chemical Engineering and Technology, North University of China, Taiyuan, People's Republic of China.
  • Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, Taiyuan, People's Republic of China.

ORCID-Profile: Haixia Ji, Xuliang Hao

Förderung

  • Young Qihuang Scholars Support Program
  • Shanxi Provincial Administration of Traditional Chinese Medicine Chinese Medicine Innovation Team Building Program
  • State Administration of Traditional Chinese Medicine High-level Chinese Medicine Key Discipline Construction Project
  • Shanxi Technology Innovation Center Project
  • Provincial Key Cultivation Laboratory for Key Technology Development of New Chinese Medicine Products
  • Shanxi Province Science and Technology Innovation Talent Team Program (Key)

Zitieren

APA

Cui, H., Ji, H., Zhang, L., Zhang, W., Kang, R., Ni, Y., & Hao, X. (2025). Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis. Phytotherapy Research. https://doi.org/10.1002/ptr.70045

Vancouver

Cui H, Ji H, Zhang L, Zhang W, Kang R, Ni Y, et al. Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis. Phytotherapy Research. 2025. doi:10.1002/ptr.70045

BibTeX
@article{Cui2025,
  author = {Cui, Hemiao and Ji, Haixia and Zhang, Lu and Zhang, Wenwen and Kang, Ruixia and Ni, Yan and Hao, Xuliang},
  title = {Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70045}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche